{"name":"Xinxin Zhang","slug":"xinxin-zhang","ticker":"","exchange":"","domain":"","description":"Xinxin Zhang is a biotechnology company focused on developing innovative mRNA-based therapies, particularly in the field of oncology. The company is currently advancing its lead candidate, an mRNA tumor vaccine therapy, through Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1LOC1BSDVORmlINmNabmpmXzhCOHQyTVQ4c3U5MGdCb1lqa2MxNFVrVmdBYjB5VmN3djU0RnN5SjBaZ3ltRU5ubExhOGNqNnVOekZPRXR6MnlwSHExNEJn?oc=5","date":"2024-02-07","type":"pipeline","source":"Nature","summary":"Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery - Nature","headline":"Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE83cklFTHZhVmVadkNaWGp6VFQzMy1wYzlOY2FSV0ktQkkxNjhmUy1EOTFtSVk2MU5NM3B2XzJoSlZmUHRPbmNscF9feGpxQXVEREpjbzlJYktmcjZ6M1Y2TjZhWjNoNy02M1N4MWRVdjBaTmIxVnMxWQ?oc=5","date":"2023-06-13","type":"pipeline","source":"Wiley","summary":"Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR-CD36 axis - Wiley","headline":"Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR-CD36 axis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE11YXhsSWVmaXZhejBLVC1fdTNiVXdaRWlWVl9hLXdveXJyaEQ2QnNWRkFPNHRmSDlhRllpUUJ2Y25DTGJmV1RMekZITjlkXzRKYjZlYnVxZXNDaTVhVGpVTWZoQlNKN2V1aGc?oc=5","date":"2021-08-25","type":"pipeline","source":"Wiley Online Library","summary":"C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth - Wiley Online Library","headline":"C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1NUkhxMWs3bmFqSDd3VnQtWUVoT25fOUZoMHVtUnpsdDlpc0hILXFVZE80TzMwY2E0eHF1R1pieVlLNTJUQUxjWnA3RzhPeHhxZ08ycG5DRGZDNTdzd0IyemtCTzRsQQ?oc=5","date":"2021-04-20","type":"trial","source":"Wiley Online Library","summary":"The efficient preparation of carbazole-based conjugated porous polymer films using electrochemical method and their fluorescence property study - Wiley Online Library","headline":"The efficient preparation of carbazole-based conjugated porous polymer films using electrochemical method and their fluo","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5lWXZFWU0xaGlIZERWY0d5bEhWUTJtVXYza1RjNnFjdE42dzJXUnVNTlRWV05pVjVkekZ2MW5Gemx1eU81dTU5MDFMLTRXMG52VFBabVJBUVpPRUw3eHVzdkJpaWh3dmpyaGVJMlB1dF83dXozUWszSkQtOA?oc=5","date":"2020-11-27","type":"pipeline","source":"ScienceDirect.com","summary":"Novel NSAIDs ophthalmic formulation: Flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect - ScienceDirect.com","headline":"Novel NSAIDs ophthalmic formulation: Flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effe","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}